These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20385221)

  • 1. The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers.
    Li F; Weng Y; Wang L; He H; Yang J; Tang X
    Int J Pharm; 2010 Jun; 393(1-2):203-11. PubMed ID: 20385221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved antitumor efficacy and reduced toxicity of liposomes containing bufadienolides.
    Hu K; Zhu L; Liang H; Hu F; Feng J
    Arch Pharm Res; 2011 Sep; 34(9):1487-94. PubMed ID: 21975810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bufadienolide-loaded submicron emulsion for oral administration: stability, antitumor efficacy and toxicity.
    Li W; Lin X; Yang Z; Zhang W; Ren T; Qu F; Wang Y; Zhang N; Tang X
    Int J Pharm; 2015 Feb; 479(1):52-62. PubMed ID: 25545797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and characterization of bufadienolides-loaded nanostructured lipid carriers.
    Li F; Wang Y; Liu Z; Lin X; He H; Tang X
    Drug Dev Ind Pharm; 2010 May; 36(5):508-17. PubMed ID: 19821716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release.
    Luan J; Zhang D; Hao L; Li C; Qi L; Guo H; Liu X; Zhang Q
    Drug Deliv; 2013 Nov; 20(8):324-30. PubMed ID: 24032657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
    Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
    Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
    Liu D; Liu Z; Wang L; Zhang C; Zhang N
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic.
    Olerile LD; Liu Y; Zhang B; Wang T; Mu S; Zhang J; Selotlegeng L; Zhang N
    Colloids Surf B Biointerfaces; 2017 Feb; 150():121-130. PubMed ID: 27907859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
    Baek JS; Pham CV; Myung CS; Cho CW
    Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface density of polyarginine influence the size, zeta potential, cellular uptake and tissue distribution of the nanostructured lipid carrier.
    Sun M; Zhu Z; Wang H; Han C; Liu D; Tian L; Yang X; Pan W
    Drug Deliv; 2017 Nov; 24(1):519-526. PubMed ID: 28181841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
    Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
    Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen nanostructured lipid carriers: enhanced in vivo antitumor efficacy with reduced adverse drug effects.
    Shete HK; Selkar N; Vanage GR; Patravale VB
    Int J Pharm; 2014 Jul; 468(1-2):1-14. PubMed ID: 24704438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice.
    Zhang XY; Qiao H; Ni JM; Shi YB; Qiang Y
    Eur J Pharm Sci; 2013 Jun; 49(3):411-22. PubMed ID: 23624327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel.
    Sun B; Luo C; Li L; Wang M; Du Y; Di D; Zhang D; Ren G; Pan X; Fu Q; Sun J; He Z
    Colloids Surf B Biointerfaces; 2016 Jul; 143():47-55. PubMed ID: 27011346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long chain lipid based tamoxifen NLC. Part II: pharmacokinetic, biodistribution and in vitro anticancer efficacy studies.
    Shete H; Chatterjee S; De A; Patravale V
    Int J Pharm; 2013 Sep; 454(1):584-92. PubMed ID: 23535344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.
    Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q
    Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells.
    Zhang XG; Miao J; Dai YQ; Du YZ; Yuan H; Hu FQ
    Int J Pharm; 2008 Sep; 361(1-2):239-44. PubMed ID: 18586075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine.
    Li S; Ji Z; Zou M; Nie X; Shi Y; Cheng G
    AAPS PharmSciTech; 2011 Sep; 12(3):1011-8. PubMed ID: 21811889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.